Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Collaborator: Boehringer Ingelheim
• Treatments: Duloxetine Hydrochloride

Criteria

Inclusion Criteria:

• Male and female outpatients at least 18 years of age

Exclusion Criteria:

• Have previously completed or withdrawn from this study or any other study investigating duloxetine or have previously been treated with duloxetine

• Patient diagnosed with major depressive disorder within the past 6 months

• Patient diagnosed with panic disorder, post-traumatic stress disorder, or an eating disorder within the past year

• History of alcohol or any psychoactive substance abuse or dependence within the past 6 months